258 related articles for article (PubMed ID: 30612452)
1. Targeting Ubiquitin Proteasome Pathway with Traditional Chinese Medicine for Treatment of Spinocerebellar Ataxia Type 3.
Chen IC; Chang CN; Chen WL; Lin TH; Chao CY; Lin CH; Lin HY; Cheng ML; Chiang MC; Lin JY; Wu YR; Lee-Chen GJ; Chen CM
Am J Chin Med; 2019; 47(1):63-95. PubMed ID: 30612452
[TBL] [Abstract][Full Text] [Related]
2.
Chen IC; Chang KH; Chen YJ; Chen YC; Lee-Chen GJ; Chen CM
Oxid Med Cell Longev; 2019; 2019():8130481. PubMed ID: 31687087
[TBL] [Abstract][Full Text] [Related]
3. A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3.
Chen ZS; Huang X; Talbot K; Chan HYE
Cell Death Dis; 2021 Feb; 12(2):136. PubMed ID: 33542212
[TBL] [Abstract][Full Text] [Related]
4. The potential of indole and a synthetic derivative for polyQ aggregation reduction by enhancement of the chaperone and autophagy systems.
Lin CH; Wu YR; Kung PJ; Chen WL; Lee LC; Lin TH; Chao CY; Chen CM; Chang KH; Janreddy D; Lee-Chen GJ; Yao CF
ACS Chem Neurosci; 2014 Oct; 5(10):1063-74. PubMed ID: 25197952
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells.
Ouyang S; Xie Y; Xiong Z; Yang Y; Xian Y; Ou Z; Song B; Chen Y; Xie Y; Li H; Sun X
Stem Cells Dev; 2018 Jun; 27(11):756-770. PubMed ID: 29661116
[TBL] [Abstract][Full Text] [Related]
6. Aqueous extract of Gardenia jasminoides targeting oxidative stress to reduce polyQ aggregation in cell models of spinocerebellar ataxia 3.
Chang KH; Chen WL; Wu YR; Lin TH; Wu YC; Chao CY; Lin JY; Lee LC; Chen YC; Lee-Chen GJ; Chen CM
Neuropharmacology; 2014 Jun; 81():166-75. PubMed ID: 24486383
[TBL] [Abstract][Full Text] [Related]
7. Shaoyao Gancao Tang (SG-Tang), a formulated Chinese medicine, reduces aggregation and exerts neuroprotection in spinocerebellar ataxia type 17 (SCA17) cell and mouse models.
Chen CM; Chen WL; Hung CT; Lin TH; Lee MC; Chen IC; Lin CH; Chao CY; Wu YR; Chang KH; Hsieh-Li HM; Lee-Chen GJ
Aging (Albany NY); 2019 Feb; 11(3):986-1007. PubMed ID: 30760647
[TBL] [Abstract][Full Text] [Related]
8. Aqueous extract of Glycyrrhiza inflata inhibits aggregation by upregulating PPARGC1A and NFE2L2-ARE pathways in cell models of spinocerebellar ataxia 3.
Chen CM; Weng YT; Chen WL; Lin TH; Chao CY; Lin CH; Chen IC; Lee LC; Lin HY; Wu YR; Chen YC; Chang KH; Tang HY; Cheng ML; Lee-Chen GJ; Lin JY
Free Radic Biol Med; 2014 Jun; 71():339-350. PubMed ID: 24675225
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3.
Gao R; Liu Y; Silva-Fernandes A; Fang X; Paulucci-Holthauzen A; Chatterjee A; Zhang HL; Matsuura T; Choudhary S; Ashizawa T; Koeppen AH; Maciel P; Hazra TK; Sarkar PS
PLoS Genet; 2015 Jan; 11(1):e1004834. PubMed ID: 25590633
[TBL] [Abstract][Full Text] [Related]
10. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
[TBL] [Abstract][Full Text] [Related]
11. Pathomechanism characterization and potential therapeutics identification for SCA3 targeting neuroinflammation.
Chiu YJ; Lin SA; Chen WL; Lin TH; Lin CH; Yao CF; Lin W; Wu YR; Chang KH; Lee-Chen GJ; Chen CM
Aging (Albany NY); 2020 Nov; 12(23):23619-23646. PubMed ID: 33196459
[TBL] [Abstract][Full Text] [Related]
12. Investigating the therapeutic effects of novel compounds targeting inflammatory IL-1β and IL-6 signaling pathways in spinocerebellar ataxia type 3.
Chen IC; Chen WL; Chang KH; Lee JW; Lin TH; Lin W; Chen CM; Lee-Chen GJ
Eur J Pharmacol; 2024 Mar; 967():176370. PubMed ID: 38320719
[TBL] [Abstract][Full Text] [Related]
13. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein.
Ashraf NS; Sutton JR; Yang Y; Ranxhi B; Libohova K; Shaw ED; Barget AJ; Todi SV; Paulson HL; Costa MDC
Neurobiol Dis; 2020 Apr; 137():104697. PubMed ID: 31783119
[TBL] [Abstract][Full Text] [Related]
14. Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance.
Li X; Liu H; Fischhaber PL; Tang TS
Prog Neurobiol; 2015 Sep; 132():34-58. PubMed ID: 26123252
[TBL] [Abstract][Full Text] [Related]
15. Lysine 117 on ataxin-3 modulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3.
Blount JR; Patel NC; Libohova K; Harris AL; Tsou WL; Sujkowski A; Todi SV
J Neurol Sci; 2023 Nov; 454():120828. PubMed ID: 37865002
[TBL] [Abstract][Full Text] [Related]
16. Spinocerebellar Ataxia Type 3 Pathophysiology-Implications for Translational Research and Clinical Studies.
Stahl F; Evert BO; Han X; Breuer P; Wüllner U
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612794
[TBL] [Abstract][Full Text] [Related]
17. Toward understanding Machado-Joseph disease.
Costa Mdo C; Paulson HL
Prog Neurobiol; 2012 May; 97(2):239-57. PubMed ID: 22133674
[TBL] [Abstract][Full Text] [Related]
18. RAN Translation of the Expanded CAG Repeats in the SCA3 Disease Context.
Jazurek-Ciesiolka M; Ciesiolka A; Komur AA; Urbanek-Trzeciak MO; Krzyzosiak WJ; Fiszer A
J Mol Biol; 2020 Dec; 432(24):166699. PubMed ID: 33157084
[TBL] [Abstract][Full Text] [Related]
19. Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes.
Ramani B; Panwar B; Moore LR; Wang B; Huang R; Guan Y; Paulson HL
Hum Mol Genet; 2017 Sep; 26(17):3362-3374. PubMed ID: 28854700
[TBL] [Abstract][Full Text] [Related]
20. DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases.
Zhang N; Bewick B; Schultz J; Tiwari A; Krencik R; Zhang A; Adachi K; Xia G; Yun K; Sarkar P; Ashizawa T
Neurotherapeutics; 2021 Jul; 18(3):1710-1728. PubMed ID: 34160773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]